1. Epigenetics
  2. Epigenetic Reader Domain

Epigenetic Reader Domain

Epigenetic regulators of gene expression and chromatin state include so-called writers, erasers, and readers of chromatin modifications.Well-characterized examples of reader domains include bromodomains typically binding acetyllysine and chromatin organization modifier (chromo), malignant brain tumor (MBT), plant homeodomain (PHD), and Tudor domains generally associating with methyllysine. Research on epigenetic readers has been tremendously influenced by the discovery of selective inhibitors targeting the bromodomain and extraterminal motif (BET) family of acetyl-lysine readers. The human genome encodes 46 proteins containing 61 bromodomains clustered into eight families. Distinct experimental approaches are used to identify the first BET inhibitors, GSK 525762A and (+)-JQ-1.

The Polycomb group (PcG) protein, enhancer of zeste homologue 2 (EZH2), has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing. This function of EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. In many types of cancers including lymphomas and leukemia, EZH2 is postulated to exert its oncogenic effects via aberrant histone and DNA methylation, causing silencing of tumor suppressor genes.

p300/CBP is not only a transcriptional adaptor but also a histone acetyltransferase.

Epigenetic Reader Domain 相关产品 (56):

Cat. No. Product Name Effect Purity
  • HY-13030
    (+)-JQ-1 Inhibitor 99.86%
    (+)-JQ-1 是一种 BET bromodomain 抑制剂,抑制 BRD4(1/2)IC50 分别为 77 nM/33 nM。
  • HY-13803
    EPZ-6438 Inhibitor 99.63%
    EPZ-6438 抑制含人PRC2的野生型EZH2Ki 为 2.5±0.5 nM。
  • HY-13470
    GSK126 Inhibitor 99.32%
    GSK126 是一种有效的选择性EZH2 甲基转移酶抑制剂,IC50 为 9.9 nM。
  • HY-15743
    OTX-015 Inhibitor 99.69%
    OTX-015 是一种有效的 BRD2/3/4 抑制剂,能够抑制细胞增殖,IC50 值为 92-112 nM。
  • HY-13032
    GSK 525762A Inhibitor 99.22%
    GSK 525762A 是一种 BET bromodomain 抑制剂,IC50 为 32.5-42.5 nM。
  • HY-100972
    ARV-771 Inhibitor 99.44%
    ARV-771 是 PROTAC 类的有效 BET 降解剂。对 BRD2, BRD3 和 BRD4 的 Kd 值分别为 4.7, 7.6 和 7.6 nM。
  • HY-12863
    CPI-0610 99.88%
    CPI-0610是一种有效的选择性 BET溴区抑制剂, 抑制BRD4-BD1, IC50值为39 nM。
  • HY-101120
    666-15 Inhibitor 98.65%
    666-15是有效选择性的CREB抑制剂,IC50值为81 nM。
  • HY-50698
    BI 2536 Inhibitor 99.19%
    BI 2536 是一种有效的选择性的 Plk1 抑制剂,IC50 为 0.83 nM,也有效抑制 BRD4IC50 为 25 nM。
  • HY-13500
    GSK343 Inhibitor 99.58%
    GSK343 是一种高效的选择性EZH2 抑制剂,IC50 为 4 nM。
  • HY-12186
    3-Deazaneplanocin A hydrochloride Inhibitor
    3-Deazaneplanocin A hydrochloride 是一种有效的组蛋白甲基转移酶 (EZH2) 抑制剂。
  • HY-15646
    UNC1999 Inhibitor 99.02%
    UNC1999 是一种有效的 SAM- 竞争性的选择性 EZH2EZH1 抑制剂,IC50 分别为 <10 nM 和 45±3 nM。
  • HY-11006
    KU-57788 Inhibitor 98.74%
    KU-57788 是一种有效的,选择性的 DNA-PK 抑制剂,并且适度抑制 BRD4BRDTIC50 值分别为 13 nM,1 μM 和 3.5 μM;同时能够激活 CRISPR/Cas9
  • HY-13235
    I-BET151 Inhibitor 98.47%
    I-BET151 是一种 BET溴区 (BET bromodomain) 抑制剂,抑制 BRD4BRD2BRD3pIC50 分别为 6.1,6.3 和 6.6。
  • HY-16954
    ARV-825 Inhibitor 99.35%
    ARV-825 是一种 PROTAC 类的 BRD4 抑制剂。ARV-825 对 BRD4 的 BD1 和 BD2 结构域具有高亲和力,Kds 值分别为 90 和 28 nM
  • HY-15826
    SGC-CBP30 Inhibitor 99.19%
    SGC-CBP30是CREBBP和EP300的布罗莫结构域抑制剂,IC50分别为21-69nM和38 nM。
  • HY-16652
    RVX-208 Inhibitor 99.19%
    RVX-208 是一种 BET 转录抑制剂,作用于 BD1BD2IC50 分别为 87±10 μM 和 0.51±0.041 μM。
  • HY-78695
    JQ-1 carboxylic acid Inhibitor 99.49%
    (+)-JQ1羧酸是(+)-JQ1的羧酸形式,用于衍生物合成。
  • HY-12856
    GSK503 Inhibitor 99.29%
    GSK503是高效特异性的EZH2甲基转移酶抑制剂,Kiapp值为3到27 nM。
  • HY-10409
    TG-101348 Inhibitor 98.28%
    TG-101348 是一种选择性的 JAK2 抑制剂,IC50 值为 3 nM;同时抑制 BRD4IC50 值为 340 nM。